X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast (1) 1
cell-free dna (1) 1
chemotherapy (1) 1
germline mutations (1) 1
maintenance therapy (1) 1
olaparib (1) 1
oncology (1) 1
secondary mutations (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer discovery, ISSN 2159-8274, 02/2019, Volume 9, Issue 2, pp. 210 - 219
A key resistance mechanism to platinum-based chemotherapies and PARP inhibitors in BRCA-mutant cancers is the acquisition of BRCA reversion mutations that... 
OLAPARIB | ONCOLOGY | SECONDARY MUTATIONS | GERMLINE MUTATIONS | MAINTENANCE THERAPY | CHEMOTHERAPY | BREAST | CELL-FREE DNA
Journal Article
Cancer discovery, 11/2018
A key resistance mechanism to platinum-based chemotherapies and PARP inhibitors in -mutant cancers is the acquisition of reversion mutations that restore... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.